Influenza Vaccine (Split Virion, Inactivated), Dalian Aleph Biomedical Co Ltd

流感病毒裂解疫苗 (大连雅立峰)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza Vaccine (Split Virion, Inactivated), Dalian Aleph Biomedical Co Ltd
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Inactivated vaccine > Split vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2005/11/10
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDalian Aleph Biomedical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDalian Aleph Biomedical Company Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A